# HI-Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hi-bio

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.hibio.com
- Total disclosed funding: $108M
- Latest round: Series B (Sep 7, 2023)
- Investors on record: 6

## About

Based in California, US, and founded in 2021, Human Immunology Biosciences, Inc. trading as HI-Bio, operates as a biotechnological company developing precision medicines to treat people suffering from autoimmune and inflammatory diseases. In November 2022, HI-Bio raised USD 120 million in venture funding from Jeito Capital, with participation from ARCH Venture Partners and Monograph Capital Partners. As of December 2022, the company is led by its CEO Travis Murdoch. 

Human Immunology Biosciences, Inc. develops a slate of precision medicines targeting cellular drivers of this dysfunction, including its lead program, the plasma depletion agent felzartamab. It provides a precision immunology toolkit consisting of four pillars human genetics, human immunophenotyping, data sciences, and therapeutic engineering that helps translate insights that emerge from ongoing research and development efforts. 

The company plans to use the venture funding to further develop precision therapeutics for patients with immune-mediated diseases.

## Funding rounds

- Series B, Sep 7, 2023, $63M — ARCH Venture Partners, Viking Global Investors, Alpha Wave Global, Arkin Capital, Jeito Capital
- Series A, Nov 15, 2022, $45M — ARCH Venture Partners, Jeito Capital, Monograph Capital
- Series A, Aug 1, 2021 — ARCH Venture Partners, Monograph Capital

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B
- Monograph Capital (https://capitalatlas.ai/funds/monograph-capital) — Series A
- Jeito Capital (https://capitalatlas.ai/funds/jeito-capital) — Series A, Series B
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series B
- Alpha Wave Global (https://capitalatlas.ai/funds/alpha-wave-global) — Series B
- Arkin Capital (https://capitalatlas.ai/funds/arkin-capital) — Series B